Our “Planto®” brand has been registered with the Turkish Patent and Trademark Office for 10 years as of 12.12.2019.
Our Planto® 3 mg Melatonin Tablet and Planto® 1 mg/ 1 ml Liquid products were released to the market in 2022 with the Planto® brand, receiving supplementary food approval.
The active ingredient Melatonin was included in the SUPPLEMENTARY FOOD RESTRICTED SUBSTANCES LIST on 07.07.2022 and its use as a supplementary food was found appropriate. However, on 09.06.2023, the use of the active ingredient Melatonin as an active ingredient in supplementary foods was not found appropriate (according to the decision No. 2022/7193 of the Council of State Tenth Chamber) and the approvals of all melatonin-containing supplementary food products were canceled and it was announced that the products that were produced and put on the market could be sold until their expiration dates expired. Due to the fact that licensed pharmaceutical products containing melatonin will be on the market in 2025, our Planto® branded products containing melatonin will not be sold as of 01.06.2025.